Sellers are Enclara founder
Humana won't say what it will pay, noting only that the deal would have no "material" impact on the
"There will be no impact to Enclara's employees, operations, and business," said Humana spokesperson
The Enclara team headed by Horowitz, a lawyer, and
Horowitz, in turn, praised Consonance as "a critical partner throughout Enclara's evolution over the past five years from a small hospice-focused pharmacy into a national full-service specialized pharmacy management platform. We look forward to the next chapter for Enclara under Humana's ownership."
Horowitz started in the pharma supply business in the 1990s with two firms,
In 2013, he added
Those businesses and Enclara's Avanti Health Care Unit will now join Humana.
The deal is expected to close next spring. Humana was advised by
Separately, NeuroFlow, a 28-person,
"In the sea of mental health [software], NeuroFlow stood out to us as being the one that was most 'clinical grade,'" said Builders VC partner
NeuroFlow will use the money to hire more marketing and data science people and boost its "product integrations and data science," working with "hundreds of providers to support the overall health of tens of thousands of individuals," said NeuroFlow chief executive
(c)2019 The Philadelphia Inquirer
Visit The Philadelphia Inquirer at www.inquirer.com
Distributed by Tribune Content Agency, LLC.